nach oben

Erschienen in:

01.12.2013 | News item

EMA to listen to patients' voice when assessing meds

Erschienen in: Reactions Weekly | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Patient involvement in the assessment of medicines, especially patient-perceived risk benefit analysis, is an area marked for further development, according to a published report from an EMA workshop titled `The patient's voice in the evaluation of medicines'.1, 2 …

EMA. European Medicines Agency explores ways to further involve patients in the benefit-risk assessment of medicines. Internet Document : 29 Oct 2013. Available from: URL: http://www.ema.europa.eu

EMA. The patient's voice in the evaluation of medicines -- How patients can contribute to assessment of benefit and risk. Internet Document : [7 pages], 18 Oct 2013. Available from: URL: http://www.ema.europa.eu

Titel: EMA to listen to patients' voice when assessing meds
Publikationsdatum: 01.12.2013
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2013
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-013-7678-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Iron

Chloramphenicol/dexamethasone/tetryzoline

Tamoxifen

Ustekinumab

Codeine phosphate/ramipril

Amlodipine overdose